Fairvalue-Calculator Fairvalue-Calculator
EN DE

NC Chem Corporation (482630) Fair Value & Analysis

Technology · KR · Market cap 338B KRW

Price19,190 KRW
Fair Value18,999 KRW
Upside-1.0%
Quality91/100
Evidence: High Range 11,505 KRW – 23,826 KRW

Fair value as of: Jun 24, 2026

Analysis

NC Chem Corporation (482630) currently trades at 19,190 KRW, while our model-based Fair Value estimate is 18,999 KRW — implying the stock looks roughly 1.0% overvalued today. We read business quality at 91/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

NC Chem Corporation produces and sells fine chemical materials for semiconductors in South Korea. It offers materials for photo process and semiconductor wet process. The company was founded in 2008 and is based in Hwaseong-si, South Korea. NC Chem Corporation is a subsidiary of Samyang Holdings Corporation.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is NC Chem Corporation (482630) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 18,999 KRW versus a price of 19,190 KRW — about −1% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 482630?
Our 21-model fair value for NC Chem Corporation is 18,999 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 19,190 KRW.
What is the quality score of 482630?
NC Chem Corporation has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.